Eudaimonia Partners, LLC
- SEC CIK
- 0001809043
- Latest filing
- Apr 25, 2024
BMY holding history
Bristol Myers Squibb Co in every 13F filed by Eudaimonia Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMY overviewAll 13F holders of BMYFull Q1 2024 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −7,270−100.0% | Sold out | Holders |
| Q3 2023 | 7,270 | $421.9K | 0.1% | +4+0.1% | Added | Holders |
| Q2 2023 | 7,266 | $464.7K | 0.1% | −2,424−25.0% | Reduced | Holders |
| Q1 2023 | 9,690 | $671.6K | 0.2% | +200+2.1% | Added | Holders |
| Q4 2022 | 9,490 | $682.8K | 0.2% | −323−3.3% | Reduced | Holders |
| Q3 2022 | 9,813 | $698.0K | 0.2% | −4,396−30.9% | Reduced | Holders |
| Q2 2022 | 14,209 | $1.09M | 0.2% | −2,047−12.6% | Reduced | Holders |
| Q1 2022 | 16,256 | $1.19M | 0.2% | – | No prior filing | Holders |
| Q4 2021 | – | – | – | – | Not filed | Holders |
| Q3 2021 | 16,435 | $972.0K | 0.2% | −1,949−10.6% | Reduced | Holders |
| Q2 2021 | 18,384 | $1.23M | 0.2% | +1,802+10.9% | Added | Holders |
| Q1 2021 | 16,582 | $1.05M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.